The White House highlighted The University of Texas at Austin's pioneering opioid overdose prevention efforts through Operation Naloxone (now housed within UT's SHIFT initiatives) and the College of Pharmacy's PhARM Program in the Biden-Harris Administration's fact sheet for its challenge to save lives from overdose.
Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.
Four Texas Pharmacy Pharm.D. students have earned recent grants and recognition by the American Association of Psychiatric Pharmacists (AAPP) Foundation.
P4 students, Megan Yeung, Kami Johnston and Morgan Murchison co-author a peer-reviewed blog in Pulses encouraging educators to adapt to reflect the specific needs of people who use drugs and patients with substance use disorders. This blog also highlights UT Pharmacy as a U.S. leader in substance use disorder and harm reduction education for Pharm.D. students.
From student scholarships to national recognition awards to prestigious appointments, the UT Pharmacy community has a lot to celebrate and be proud of right now.
Tara Law from Time writes about how few pharmacies carry buprenorphine, a life-saving drug to help treat opioid use disorder (OUD). Lucas Hill, Pharm.D., BCACP, director of the college's Pharmacy Addictions Research & Medicine (PhARM) program, offers his insight on the issue, and how the DEA's crackdown of the drug puts OUD patients at risk.
Second year student pharmacist Tiffany Dinh is one of two students in the country awarded Pharmacist To Be by the GoodRx Above & Beyond Pharmacy Awards. This honor recognizes students who are dedicated to learning all aspects of the pharmacy trade and who show outstanding initiative and leadership.
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.